SCHEMBL7264604

SCHEMBL7264604

CC(=O)n1c(=O)ccc2cccc(O)c21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MEN1 O00255 1/20 0.42
THRB P10828 1/20 0.38
MAOA P21397 2/20 0.37
MAOB P27338 1/20 0.37
MAPT P10636 1/20 0.36
CDK2 P24941 1/20 0.36
POLB P06746 1/20 0.35
CA9 Q16790 3/20 0.34
CA12 O43570 2/20 0.34
BRD4 O60885 1/20 0.34
BRPF1 P55201 1/20 0.34
KAT2B Q92831 1/20 0.34
BRD9 Q9H8M2 1/20 0.34
METAP2 P50579 1/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11871173 0.82 KDM2B (0.40) HTR2AGAA
SCHEMBL3107572 0.77 MAPT (0.50) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL30672091 0.73 CA12 (0.55) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL6568800 0.73 CA12 (0.55) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL27629282 0.71 MAPT (0.36) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL10967544 0.64 CA12 (0.41) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL29219227 0.64 POLB (0.43) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL28706031 0.63 POLB (0.53) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL28320396 0.63 KCNMA1 (0.44) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL2052186 0.62 CYP1A2 (0.38) KDM4EKMT2AALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003042160-A1 ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONISTS THERAVANCE, INC. (US) 2003-05-22 WO disclosed